Royalty Pharma plc (RPRX)

Royalty Pharma (RPRX) stock nears 52-week high amid strong Q3 performance and strategic acquisitions. Analyst upgrade to 'Buy' from UBS further bolsters positive sentiment.

About Royalty Pharma plc

Royalty Pharma plc is a biopharmaceutical royalty company that invests in and acquires royalty interests in innovative medicines.
Royalty Pharma plc uses the ticker $RPRX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Royalty Pharma plc (RPRX) social dominance is up 300% from the previous week.
Royalty Pharma plc (RPRX) Galaxy Score™ is up 46.43% from the previous week.
Royalty Pharma plc (RPRX) engagements is up 774.13% from the previous week.
Royalty Pharma plc (RPRX) posts created is up 93.33% from the previous week.
Royalty Pharma plc Price hit a 52-Week high of $45.70 for the hour

Price: $45.20

Price 24-Hour Time-Series Raw Data
The stock price is near a 52-week high, supported by positive market sentiment, recent dealmaking like the Evrysdi royalty acquisition, strong Q3 performance, and strategic buybacks, with social sentiment reinforcing this bullish trend. An analyst upgrade to 'Buy' from UBS further bolsters this positive price action.

24-Hour: 0.87% 7-Day: 1.55% 30-Day: 14.26%

1-Year High: $45.20 on 2026-02-13
1-Year Low: $30.90 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Royalty Pharma plc (RPRX) is currently AltRank #1,498 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +28
[--] Month: [-----] +1,430
[--] Months: [-----] +543
[--] Year: [-----] +1,339
1-Year High: [-----] on 2026-02-15
1-Year Low: [---] on 2025-07-04

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +13
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-17
1-Year Low: [--] on 2025-10-10

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] +774%
[--] Month: [-------] +61%
[--] Months: [-------] +5.80%
[--] Year: [---------] -38%
1-Year High: [------] on 2025-08-25
1-Year Low: [---] on 2026-01-03

Engagements by network (24h): News: [--] TikTok: [--] X: [---] YouTube: [--] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -13%
[--] Month: [---] +55%
[--] Months: [-----] -9.60%
[--] Year: [-----] +14%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2026-01-01

Mentions by network (24h): News: [--] TikTok: [--] X: [--] YouTube: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Royalty Pharma plc (RPRX) in the last [--] hours which is up 5.30% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] -3.50%
[--] Month: [---] +47%
[--] Months: [---] -46%
[--] Year: [-----] +36%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2026-01-01

The most influential creators that mention Royalty Pharma plc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@PonPonRon2	[--]	[---]	[--]	[---]
@SheliaL53055245	[--]	[---]	[--]	[--]
@jedimarkus77	[--]	[------]	[--]	[--]
@d8rader69	[--]	[--]	[--]	[--]

Sentiment: 57%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 57%
Daily Average: 72%
[--] Week: 25% -75%
[--] Month: 62% +19%
[--] Months: 62% -7%
[--] Year: 62% -2%
1-Year High: 100% on 2025-03-16
1-Year Low: 15% on 2025-12-18

Most Supportive Themes:

Royalty Pharma's Financial Performance and Strategy: (30%) Discussions highlight Royalty Pharma's financial guidance, including expected shareholder returns and cash flow, alongside its strategic approach to acquiring biopharmaceutical royalties.
Biopharmaceutical Investments and Partnerships: (25%) Posts frequently mention Royalty Pharma's involvement in funding and acquiring stakes in biopharmaceutical companies and their drug royalties, indicating strategic partnerships and investment potential.
Stock Performance and Valuations: (20%) Analysis of Royalty Pharma's stock performance, including price targets, and comparisons to other healthcare stocks, suggests a focus on its investment value.

Most Critical Themes:

Valuation Comparisons and Market Sentiment: (15%) Some posts compare Royalty Pharma's valuation multiples to other sectors, suggesting potential overvaluation or a need for further justification of its current market position.
Insider Trading and Ownership Changes: (10%) Mentions of insider trading activity, including CEO stock purchases and past ownership by notable investors, prompt scrutiny and analysis of the company's internal confidence and strategic direction.

Social Dominance: 0.00349%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00349%
Daily Average: 0.00939%
[--] Week: 0.004% +0.003%
[--] Month: 0.0037% +0.00010000000000000026%
[--] Months: 0.0037% -0.0018%
[--] Year: 0.0037% -0.013%
1-Year High: 0.042% on 2025-06-29
1-Year Low: 0.002% on 2025-09-30

Market Dominance: 0.022%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.022%
Daily Average: 0%
1-Year High: 0.506% on 2025-03-31
1-Year Low: 0.018% on 2025-10-28

Market Cap: $19,360,237,076

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $19,360,237,076
Daily Average: $15,558,762,580
[--] Week: $19,355,952,890 +2.80%
[--] Month: $19,360,237,076 +15%
[--] Months: $19,360,237,076 +21%
[--] Year: $19,360,237,076 +38%
1-Year High: $19,360,237,076 on 2026-02-13
1-Year Low: $13,371,776,306 on 2025-04-08